Humacyte Inc Warrant
HUMAW
6 hedge funds and large institutions have $168K invested in Humacyte Inc Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
7% more capital invested
Capital invested by funds: $157K → $168K (+$11.2K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.08% less ownership
Funds ownership: 0.35% → 0.28% (-0.08%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$8.95K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.96K |
| 3 |
Jane Street
New York
|
+$117 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$8.68K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.24K |
HUMAW Hedge Fund Activity: Q2 2025 in Review
6 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q2 2025, worth a combined $168K — up 7.2% from $157K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new HUMAW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $8.95K. The largest seller was LPL Financial, cutting an estimated $8.68K.
- 6 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q2 2025, up from 5 in Q1 2025.
- Funds reported $168K of Humacyte Inc Warrant stock for Q2 2025, up 7.2% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest Humacyte Inc Warrant buyer in Q2 2025 was Toronto Dominion Bank, an estimated $8.95K added.
- The largest Humacyte Inc Warrant seller in Q2 2025 was LPL Financial, an estimated $8.68K sold.
Based on aggregated 13F filings for Q2 2025.